lobbying_activities: 2826061

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2826061	67527880-adc7-4d5f-a24e-eacd8f02d813	Q2	ALB SOLUTIONS	401105973	BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.	2022	second_quarter	PHA	Issues related to regulatory and legislative developments regarding biosimilars.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2022-07-18T17:47:40-04:00